Chemistree Technology Escapes Junior CSE Downdraft With Uptrend Still Intact

Chemistree Technology Escapes Junior CSE Downdraft With Uptrend Still Intact

  • Monday, May 13th, 2019

Although the cannabis market has a miserable time of it this week, Chemistree Technology Inc (CNSX:CHM) (OTCMKTS:CHMJF) (FRA:CM1) price trend remains pointed up—for now. While investors can’t exactly let their guard down, the company will nonetheless take this price action status quo 100% of the time. For the week, the numbers point to a sector weakness across […]

► READ MORE

Chemistree Technology Inc (CNSX:CHM) Expanding Premium Brand Sugarleaf Offerings

Chemistree Technology Inc (CNSX:CHM) Expanding Premium Brand Sugarleaf Offerings

  • Thursday, May 9th, 2019

https://youtu.be/J9CCNjSS14g Chemistree Technology Inc (CNSX:CHM) (OTCMKTS:CHMJF) (FRA:CM1) CCO Sheldon Aberman shares details of his extensive experience in the hydroponic and cannabis industries, which includes designing and building facilities, cultivating product, and providing consulting services. Aberman discusses the construction of Chemistree’s 128,000 square foot greenhouse complex and its 40,000 square foot manufacturing and distribution building, in […]

► READ MORE

INITIAL RESEARCH REPORT SHOWS SIGNIFICANT UPSIDE POTENTIAL FOR CHEMISTREE TECHNOLOGY IN CANNABIS SECTOR

INITIAL RESEARCH REPORT SHOWS SIGNIFICANT UPSIDE POTENTIAL FOR CHEMISTREE TECHNOLOGY IN CANNABIS SECTOR

  • Monday, May 6th, 2019

Chemistree Technology Inc. (CA:CHM – $0.65 & US:CHMJF – $0.48 & GER:CM1 – €0.44) is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry. The Company believes the cannabis industry offers a tremendous opportunity for growth. The reason for this is simply that marketing of cannabis […]

► READ MORE

Chemistree Acquires Ownership Stake in The Physician’s Choice CBD LLC

Chemistree Acquires Ownership Stake in The Physician’s Choice CBD LLC

  • Monday, April 29th, 2019

– Doctor created, CBD from Hemp Pain Management Company VANCOUVER, April 29, 2019 – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that the Company has entered into a funding agreement with The Physician’s Choice CBD LLC of Phoenix, Arizona. The Physician’s Choice CBD (“PCCBD”) is dedicated to […]

► READ MORE

Chemistree Provides California and Washington Operations Update

Chemistree Provides California and Washington Operations Update

  • Thursday, April 18th, 2019

VANCOUVER, April 18, 2019  – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to provide shareholders with an update on the Company’s Washington State assets and its Desert Hot Springs, California cultivation facility development. Chemistree has received reports from its Washington state licensee partner that further advancements have been made in crucial areas of […]

► READ MORE

CHEMISTREE ANNOUNCES PARTNERSHIP WITH NEW JERSEY MEDICAL RETAIL CANNABIS LICENSE APPLICANT

CHEMISTREE ANNOUNCES PARTNERSHIP WITH NEW JERSEY MEDICAL RETAIL CANNABIS LICENSE APPLICANT

  • Monday, April 15th, 2019

Vancouver, British Columbia, April 15, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that its wholly owned U.S. subsidiary, American CHM Investments Inc., has signed a letter of intent (LOI) to partner with Applied Cannabis Sciences of New Jersey (“ACS”), a New Jersey-based medical retail […]

► READ MORE

CHEMISTREE APPOINTS NICO ESCONDIDO TO BOARD OF DIRECTORS

CHEMISTREE APPOINTS NICO ESCONDIDO TO BOARD OF DIRECTORS

  • Tuesday, April 9th, 2019

– HIGH TIMES OWNER & CHIEF CANNABIS OFFICER – FOUNDER OF THE CANNABIS GENETICS INSTITUTE – LEADING INDUSTRY RESEARCHER & EDUCATOR Vancouver, British Columbia, April 9, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce the appointment of Mr. Nicholas J. Zitelli to its Board of […]

► READ MORE

CHEMISTREE GRANTS STOCK OPTIONS – Restarts Digital Marketing Intiatives

CHEMISTREE GRANTS STOCK OPTIONS – Restarts Digital Marketing Intiatives

  • Monday, April 8th, 2019

Vancouver, British Columbia, April 5, 2019 – Chemistree Technology Inc. (Canadian Securities Exchange: CHM and CHM.WT) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) pursuant to the Company’s stock option plan — has granted options to purchase 1,300,000 common shares at $0.60 per share to certain eligible directors, officers and consultants. The options expire in five […]

► READ MORE

CHEMISTREE ANNOUNCES CLOSING OF PROSPECTUS OFFERING AND CONCURRENT PRIVATE PLACEMENT

CHEMISTREE ANNOUNCES CLOSING OF PROSPECTUS OFFERING AND CONCURRENT PRIVATE PLACEMENT

  • Friday, March 29th, 2019

Vancouver, British Columbia, March 29, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) announced today that it has closed its previously announced short form prospectus offering (the “Brokered Offering”) and concurrent private placement (the “Concurrent Private Placement”) of 10% unsecured debenture units (the “Debenture Units”) of the Company, for […]

► READ MORE

CHEMISTREE ANNOUNCES FILING OF FINAL SHORT-FORM PROSPECTUS AND CONCURRENT PRIVATE PLACEMENT

CHEMISTREE ANNOUNCES FILING OF FINAL SHORT-FORM PROSPECTUS AND CONCURRENT PRIVATE PLACEMENT

  • Thursday, March 28th, 2019

Vancouver, British Columbia, March 25, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) announced today that it has filed and obtained a receipt for a final short form prospectus in each of the provinces of Canada, other than Québec, in connection with its previously announced offering (the “Offering”) of […]

► READ MORE